Clene Inc. share price logo

Clene Inc.

NASDAQ: CLNN

$6.10

-0.03

(-0.49%)

as on

Clene Inc. Stock Performance

as on July 3, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $6.03
    $6.38
    downward going graph

    1.15%

    Downside

    4.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $3.25
    $13.50
    downward going graph

    46.72%

    Downside

    121.31%

    Upside

    downward going graph

Clene Inc. share price movements today

Previous Close
$6.13
Open
$6.20
Volume
336.4K
Day's Low - High
$6.03 - $6.38
52 Week Low - High
$3.25 - $13.50

Clene Inc. Historical Returns

1 Month Return
+ 5.9 %
3 Month Return
+ 19.14 %
1 Year Return
+ 56.41 %
3 Year Return
-64.94 %
5 Year Return
-97.19 %

Clene Inc. Stock Fundamentals & Key Indicators

Check Clene Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$78.7M

EPS (TTM)

-1.405

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.61%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.6M

Revenue (TTM)

134.0K

Profit Margin

0.00%

Return On Equity TTM

-1738.36%

Clene Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Clene Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Clene Inc. image
Clene Inc.
BUY$78.7M-97.19%NA0.00%NA
The Kraft Heinz Company image
The Kraft Heinz Company
BUY$29.7B-37.17%NA-23.05%6.77%
General Mills Inc. image
General Mills Inc.
HOLD$20.2B-37.61%9.2312.05%6.98%
JBS N.V. image
JBS N.V.
NA$39.7BNA7.451.98%8.44%

Stock Returns calculator for Clene Inc. Stock including INR - Dollar returns

The Clene Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Clene Inc. investment value today

Current value as on today

₹1,74,162

Returns

₹74,162

(+74.16%)

Returns from Clene Inc. Stock

₹56,410 (+56.41%)

Dollar Impact

₹17,752 (+17.75%)

Analyst Recommendation on Clene Inc. Stock

Based on 11 analysts

BUY

90.91%

Buy

9.09%

Hold

0.00%

Sell

Based on 11 analysts, 90.91% of analysts recommend a 'BUY' rating for Clene Inc.. Average target price of $32.2

Clene Inc. Share Price Target

Get share price movements and forecasts by analysts on Clene Inc..

What analysts predicted

81.06%UPSIDE

Target Price

$32.2

Current Price

$6.1

Analyzed by

11 Analysts

Target

$32.20

Clene Inc. target price $32.2, a slight upside of 81.06% compared to current price of $6.1. According to 11 analysts rating.

Indian Investors' Interest in Clene Inc. Stock

Search interest for Clene Inc. Stock has decreased by -57% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-57% versus previous 30 day period

Clene Inc. Quarterly Profit & Loss

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
0
0
0
0
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
0
0
0
Operating Income
-9
-9
-7
-7
-8
-4
-5
-5
-7
-2
EBITDA
-8
-9
-5
-6
-12
0
-6
-7
-8
-6
Interest Expense
1
1
1
1
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-10
-11
-6
-7
-13
0
-7
-8
-9
-8
Income Tax Expense
12
0
0
-
-
-
-
-
-
-
Net Income
-10
-11
-6
-7
-13
0
-7
-8
-9
-8
Net Profit Margin
-5984.12%
-15178.08%
-7456.04%
-9179.31%
-14889.01%
-927.16%
-27477.78%
-58513.33%
-11981.82%
-53939.99%

Clene Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
0
0
0
0
0
0
Gross Profit
0
0
0
0
0
0
0
Operating Income
-16
-20
-49
-48
-40
-33
-23
EBITDA
-15
-16
-8
-25
-43
-33
-21
Interest Expense
0
0
0
3
4
4
2
Depreciation
0
0
0
1
1
1
1
Income Before Tax
-16
-18
-10
-29
-49
-39
-26
Income Tax Expense
0
0
0
-14
1
-
-
Net Income
-16
-19
-9
-29
-49
-39
-26
Net Profit Margin
0.00%
-9357.77%
-1347.16%
-6325.16%
-7569.42%
-11520.47%
-13086.50%

Clene Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Net Income
-11
-6
-7
-13
0
-7
-8
-9
-8
Operating Cash Flow
-7
-6
-3
-4
-5
-4
-3
-4
-4
Investing Cash Flow
0
6
0
0
-
-
0
0
-
Financing Cash Flow
0
0
-4
2
2
2
4
2
5
Change in Cash
-7
0
-7
-2
-2
-2
0
-2
0

Clene Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-16
-19
-9
-29
-49
-39
-26
Operating Cash Flow
-13
-18
-34
-39
-30
-21
-18
Investing Cash Flow
0
0
-1
-10
-1
6
0
Financing Cash Flow
5
69
27
17
42
-1
11
Change in Cash
-7
50
-8
-31
10
-16
-6

Insights on Clene Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, CLNN stock has moved up by 56.4%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -9.22M → -8.09M (in $), with an average increase of 14.0% per quarter

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, CLNN has outperformed top 5 stocks with highest market-cap in its industry

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Clene Inc. Common Stock has experienced a drawdown of -64.1%, however The Kraft Heinz Company Common Stock resisted the overall trend and outperformed by 34.9%

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 77.0K → 15.0K (in $), with an average decrease of 80.5% per quarter

About Clene Inc.

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. The company's lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases. It develops CNM-AgZn17, a gel polymer suspension of silver and zinc ions that is being developed for the treatment of infectious diseases and to support wound healing; and CNM-ZnAg, a broad-spectrum antiviral and antibacterial agent to treat infection disease and to provide immune support for symptom resolution. In addition, the company markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement; and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene Inc. is headquartered in Salt Lake City, Utah.
OrganisationClene Inc.
Headquarters6550 South Millrock Drive, Salt Lake City, UT, United States, 84121
IndustryPackaged Foods
CEOMr. Robert Etherington MBA
E-voting on sharesClick here to vote

Key Management of Clene Inc.

Name

Title

Mr. Jerry Miraglia J.D.

General Counsel & Corporate Secretary

Ms. Mary Anne Mcneil

Head of Human Resources

Mr. Michael T. Hotchkin

Chief Development Officer

Dr. Benjamin M. Greenberg M.D., M.H.S.

Head of Medical

Mr. Robert Etherington MBA

CEO, President & Director

Mr. Morgan R. Brown CPA, M.B.A.

Chief Financial Officer

Mr. Mark G. Mortenson ESQ.

Chief Science Officer

FAQs

What is Clene Inc. share price today?

Clene Inc. share price today is $6.10 as on at the close of the market. Clene Inc. share today touched a day high of $6.38 and a low of $6.03.

What is the 52 week high and 52 week low for Clene Inc. share?

Clene Inc. share touched a 52 week high of $13.50 on and a 52 week low of $3.25 on . Clene Inc. stock price today i.e. is closed at $6.10,which is 54.81% down from its 52 week high and 87.69% up from its 52 week low.

What is Clene Inc.'s market capitalisation today?

Clene Inc. market capitalisation is $0.00T as on .

How to invest in Clene Inc. Stock (CLNN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Clene Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Clene Inc. Shares that will get you 0.2459 shares as per Clene Inc. share price of $6.10 per share as on July 3, 2026 at 8:45 am IST.

What is the minimum amount required to buy Clene Inc. Stock (CLNN) from India?

Indian investors can start investing in Clene Inc. (CLNN) shares with as little as ₹95.2 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹952.00 in Clene Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Clene Inc. share’s latest price of $6.10 as on July 3, 2026 at 8:45 am IST, you will get 1.6393 shares of Clene Inc.. Learn more about fractional shares .

What are the returns that Clene Inc. has given to Indian investors in the last 5 years?

Clene Inc. stock has given -97.19% share price returns and 28.17% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?